rs11552145
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002591.4(PCK1):c.826G>A(p.Glu276Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.183 in 1,609,592 control chromosomes in the GnomAD database, including 29,379 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002591.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCK1 | NM_002591.4 | c.826G>A | p.Glu276Lys | missense_variant | 6/10 | ENST00000319441.6 | |
PCK1 | XM_024451888.2 | c.430G>A | p.Glu144Lys | missense_variant | 5/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCK1 | ENST00000319441.6 | c.826G>A | p.Glu276Lys | missense_variant | 6/10 | 1 | NM_002591.4 | P1 | |
PCK1 | ENST00000467047.1 | n.2513G>A | non_coding_transcript_exon_variant | 1/2 | 1 | ||||
PCK1 | ENST00000498194.1 | n.768G>A | non_coding_transcript_exon_variant | 3/3 | 2 | ||||
PCK1 | ENST00000470051.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.146 AC: 22132AN: 152056Hom.: 2061 Cov.: 32
GnomAD3 exomes AF: 0.164 AC: 41015AN: 250492Hom.: 3966 AF XY: 0.169 AC XY: 22853AN XY: 135420
GnomAD4 exome AF: 0.187 AC: 272059AN: 1457418Hom.: 27316 Cov.: 30 AF XY: 0.188 AC XY: 136077AN XY: 725282
GnomAD4 genome ? AF: 0.146 AC: 22146AN: 152174Hom.: 2063 Cov.: 32 AF XY: 0.146 AC XY: 10834AN XY: 74388
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 15, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Phosphoenolpyruvate carboxykinase deficiency, cytosolic Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at